U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
151501151501Lung Cancer Location: a RepositoryTerminatedNo Results AvailableLung Cancerhttps://ClinicalTrials.gov/show/NCT00578084
151502151502Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal CancerCompletedHas ResultsCancer of the EsophagusDrug: Panitumumab|Drug: Capecitabine|Drug: Oxaliplatin|Radiation: Radiation Therapy (RT)https://ClinicalTrials.gov/show/NCT00578071
151503151503Randomized Trial Of Tinnitus Retraining TherapyCompletedNo Results AvailableTinnitusOther: Counseling and Sound Therapyhttps://ClinicalTrials.gov/show/NCT00578058
151504151504Human Cord Blood Transplantation in Advanced Hematological MalignanciesWithdrawnNo Results AvailableMultiple MyelomaProcedure: Transfusionhttps://ClinicalTrials.gov/show/NCT00578045
151505151505Reconstructive Surgery For Head And Neck Cancer PatientsActive, not recruitingNo Results AvailableAdvanced Stage Head and Neck CancerBehavioral: Quality of Life Questionaires & Interview: EORTC QLQ C-30, EORTC QLQ H&N-35, Health Behaviors, Subjective Significance Questionnaire, Qualitative Assessmenthttps://ClinicalTrials.gov/show/NCT00578032
151506151506Comparison Between LISS Plating and Intramedullary (IM) Nailing for Supracondylar Femur FracturesCompletedNo Results AvailableSupracondylar Femur FractureProcedure: IM Nailing|Procedure: LISShttps://ClinicalTrials.gov/show/NCT00578019
151507151507Internet-based System for Cancer Patients to Self-report ToxicityActive, not recruitingNo Results AvailableCervical Cancer|Lung Cancer|Prostate Cancer|Vaginal Cancer|Ovarian Cancer|Breast Cancer|Bladder CancerBehavioral: Questioners|Behavioral: STAR websitehttps://ClinicalTrials.gov/show/NCT00578006
151508151508Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsActive, not recruitingNo Results AvailableLymphomaDrug: Fludarabine|Drug: Novantrone|Drug: Decadron|Drug: Rituximab|Drug: Interferon|Drug: Doxorubicin|Drug: Vincristine|Drug: Bleomycin|Drug: Cyclophosphamide|Drug: Etoposide|Drug: Cisplatin|Drug: Ara-C|Drug: Methyl-Prednisolone|Drug: Procarbazine|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00577993
151509151509Testosterone in Castration-Resistant Prostate CancerWithdrawnNo Results AvailableProstate CancerDrug: Testosteronehttps://ClinicalTrials.gov/show/NCT00577980
151510151510Gabapentin - A Solution to Uremic Pruritus?Not yet recruitingNo Results AvailablePruritus|UremiaDrug: Gabapentinhttps://ClinicalTrials.gov/show/NCT00577967
151511151511Multimodal Resonance Imaging for Outcome Prediction on Coma PatientsCompletedNo Results AvailableComaProcedure: Multimodal MRIhttps://ClinicalTrials.gov/show/NCT00577954
151512151512Value of Fecal CalprotectinCompletedNo Results AvailableCalprotectin|Inflammatory Bowel Diseasehttps://ClinicalTrials.gov/show/NCT00577928
151513151513Breast MRI SpectroscopyActive, not recruitingNo Results AvailableSuspicion of, or Known Breast CancerOther: Radiology/MRI scanhttps://ClinicalTrials.gov/show/NCT00577915
151514151514Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving ChemoradiationCompletedNo Results AvailableHead and Neck CancerOther: Observationhttps://ClinicalTrials.gov/show/NCT00577902
151515151515Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic CancerCompletedHas ResultsAdenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic CancerDrug: gemcitabine hydrochloride|Drug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00577889
151516151516Assessment of the Functional Significance of Accessory Pudendal ArteriesCompletedNo Results AvailableProstate CancerProcedure: Trimix Injection with Doppler Ultrasoundhttps://ClinicalTrials.gov/show/NCT00577876
151517151517Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide TherapyCompletedHas ResultsOsteoporosisDrug: teriparatidehttps://ClinicalTrials.gov/show/NCT00577863
151518151518Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral DoseCompletedNo Results AvailableOsteopenia|OsteoporosisDrug: risedronate|Drug: alendronatehttps://ClinicalTrials.gov/show/NCT00577850
151519151519Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMDCompletedNo Results AvailablePostmenopausalDrug: risedronate|Drug: risedronate|Drug: risedronate|Drug: experimentalhttps://ClinicalTrials.gov/show/NCT00577837
151520151520Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)CompletedHas ResultsType 2 DiabetesDrug: exenatide|Drug: exenatide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00577824
151521151521Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs PlansCompletedNo Results AvailableHIV Infections|Mental Healthhttps://ClinicalTrials.gov/show/NCT00577811
151522151522Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving DoxorubicinActive, not recruitingNo Results AvailableCardiac Toxicity|Chemotherapeutic Agent Toxicity|LymphomaDrug: doxorubicin hydrochloride|Procedure: contrast-enhanced magnetic resonance imaginghttps://ClinicalTrials.gov/show/NCT00577798
151523151523Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy SurgeryCompletedNo Results AvailableCystectomyOther: tissue procurementhttps://ClinicalTrials.gov/show/NCT00577785
151524151524Transit Time and Bacterial Overgrowth Using SmartPill CapsuleTerminatedHas ResultsSmall Bowel Bacterial Overgrowth|Gastrointestinal Diseases|Stomach Diseases|Digestive System DiseasesDrug: Xifaxan|Device: SmartPill|Procedure: Lactulose hydrogen breath test (H_2BT)https://ClinicalTrials.gov/show/NCT00577772
151525151525Community and Clinician Partnership for PreventionCompletedNo Results AvailablePhysical Activity|Dietary Habits|Tobacco Use CessationOther: Active Intervention|Other: Passive Intervention|Other: No interventionhttps://ClinicalTrials.gov/show/NCT00577759
151526151526Clinical Impact of EUS in Staging NSCLCCompletedNo Results AvailableNon Small Cell Lunghttps://ClinicalTrials.gov/show/NCT00577746
151527151527Study of the Physiology of the Asthma of the Obese Subjects. Breathing Obesity Asthma Study (BOA)CompletedNo Results AvailableAsthma|Obesityhttps://ClinicalTrials.gov/show/NCT00577733
151528151528Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly RisedronateCompletedHas ResultsPostmenopausal WomenDrug: risedronate|Drug: risedronate|Drug: risedronate|Drug: risedronatehttps://ClinicalTrials.gov/show/NCT00577720
151529151529Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)CompletedNo Results AvailableNon Small Cell Lung Cancer|Lung CancerDrug: pemetrexed, cisplatin and erlotinib before surgery then erlotinib is given to patients after surgery for 2 yearshttps://ClinicalTrials.gov/show/NCT00577707
151530151530Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableLeukemiaDrug: clofarabine|Drug: gemtuzumab ozogamicinhttps://ClinicalTrials.gov/show/NCT00577694

* Görseller ve İçerik tekif hakkına sahip olabilir